India’s medical tourism sector has moved past its early identity as a low-cost alternative to Western healthcare. Government estimates put the market at close to USD 13 billion by the end of this year, more than double its 2022 value, and the growth is no longer being driven by price alone. The Heal in India initiative, a national Medical Value Travel portal, the e-Medical Visa and the newer AYUSH Visa, and this year’s Union Budget commitment to five regional Medical Value Travel hubs have turned what was once a fragmented, agent-led industry into something closer to a coordinated national programme. For healthcare leaders, that is the real story of 2026. India is no longer competing on cost alone. It is competing on infrastructure, credentialing and the patient’s confidence that the care on offer is exactly what it claims to be.

One example of this shift is CureMeAbroad, an AI-native discovery and concierge platform that connects international patients from the UK, US, Germany, Australia and the GCC with a curated network of more than 1,500 hospitals and 3,600 doctors across 38-plus destinations, spanning India alongside Turkey, Thailand, Mexico and Georgia. Rather than aggregating every listing it can source, the platform positions its value in exclusion: hospitals are vetted before listing and delisted the moment accreditation lapses, and every treatment estimate is confirmed in writing before a patient travels. As a participant in the United Nations Global Compact with more than 20,000 recorded patient experiences on its platform.

Domestic hospital groups, among them Apollo, Fortis, Medanta, Manipal, Max and Narayana Health, have spent the past two years building dedicated international patient wings, insurer partnerships and multilingual concierge desks, treating outbound-facing infrastructure as core strategy rather than an add-on. Alongside them sits a second, less visible layer of Indian-born and global discovery and facilitator platforms doing the job hospitals were never built to do well: helping a patient thousands of miles away compare, verify and commit before they board a flight. International entrants, from global health insurers exploring provider partnerships to overseas facilitator networks opening India-facing desks, are treating the growing specialisation within this ecosystem as a sign that the market has matured beyond scale for its own sake.

The sector’s next constraint is not capacity. It is credibility. NABH and JCI accreditation are widely cited by hospitals and platforms alike, but accreditation is a point-in-time claim, not a standing guarantee, and the gap between an approved hospital and an actively monitored one is where patient trust is won or lost. The government’s push toward ISO 22525 standardisation for wellness services and a unified digital health record under the Ayushman Bharat Digital Mission is a direct response to that gap. For any organisation operating in this category, authenticity is becoming an operating discipline rather than a marketing claim: continuous verification, published exclusions alongside published partnerships, and pricing confirmed in writing rather than quoted verbally.

For healthcare leaders weighing expansion into or through India in 2026, three imperatives stand out. First, build for the corridor, not the country. A UK cardiac patient, a GCC fertility patient and a US orthopaedic patient are moving through entirely different visa, insurance and aftercare paths, and treating them identically is where many facilitator models fail. Second, treat verification as infrastructure rather than compliance. Real-time accreditation checks, published pricing and a named point of contact are now baseline expectations, not differentiators. Third, plan for the full patient journey rather than the transaction. A patient who travels for treatment and recovers without incident does more for a hospital’s reputation, and for the sector’s reputation, than a dozen enquiries that go no further than a price comparison.

Also Read: The GLP-1 revolution: Is India ready for the next era of obesity treatment?

India’s medical tourism sector spent the last decade proving it could be cheaper. In 2026, it is being asked to prove it can be trusted, at scale, by patients who will not meet their care team in person until the day they land. The organisations that treat that as the actual mandate, and not as a marketing line, are the ones that will define the next phase of the industry.

Views expressed by: Aditya Oza, CEO & Co-Founder, CureMeAbroad

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Disclaimer: The views and opinions expressed in this article are solely those of the author and do not necessarily reflect the official policy or views of any organisation. The content is intended for informational and educational purposes only and should not be construed as medical advice.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!